Alembic Pharma Gains On Drug Approval

Alembic Pharma Gains On Drug Approval

Shares of the Vadodara-based pharmaceutical firm rose as much as 5.4 percent to Rs 570.

Alembic Pharmaceuticals has received approval from the U.S. drug regulator for Acyclovir, which is used in the treatment of genital herpes, it said in a notification to the stock exchanges.

Spread the love

Neal Bhai has been involved in the Bullion and Metals markets since 1998 – he has experience in many areas of the market from researching to trading and has worked in Delhi, India. Mobile No. - 9899900589 and 9582247600

Leave a Comment